aluates Reports

$ 0.0

Automative

Global Pharmacogene Testing Market Research Report 2025

Published Date: 2025-12-08

Report Code: QYRE-Auto-11C16646

Global Pharmacogene Testing Market Research Report 2023

BUY CHAPTERS

Global Pharmacogene Testing Market Research Report 2025

Code: QYRE-Auto-11C16646

Report

2025-12-08

Pages:120

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

Pharmacogene Testing Market Size

The global market for Pharmacogene Testing was valued at US$ 610 million in the year 2024 and is projected to reach a revised size of US$ 1280 million by 2031, growing at a CAGR of 10.5% during the forecast period.

Pharmacogene Testing Market

Pharmacogene Testing is a precision medicine technology that uses molecular biology techniques to analyze gene sequence variations in individuals related to drug metabolism, efficacy, and safety. It predicts the absorption, distribution, metabolism, and excretion (ADME) processes of drugs in the body, as well as therapeutic responses and adverse reaction risks, providing a scientific basis for the development of personalized clinical medication regimens.

Technological innovation is the core driving force behind market development. On the one hand, mainstream technologies are constantly being optimized. High-throughput sequencing (NGS) is deeply integrated with technologies such as multiplex PCR and microarray chips, which not only improves detection throughput and accuracy but also significantly reduces costs. On the other hand, new technologies are gradually being implemented. Breakthroughs in CRISPR gene editing technology and AAV delivery systems have promoted the popularization of personalized treatment plans. Nanopore sequencing technology has shortened the tumor mutation burden detection cycle to 8 hours, and CRISPR-Cas9-assisted targeted enrichment technology has reduced the DNA input requirements, adapting to more clinical sample scenarios. In addition, the integration of AI technology and gene data analysis has become a new direction, enabling in-depth mining of data on the correlation between genes and drug phenotypes, improving the efficiency and accuracy of clinical interpretation of test reports.

This report aims to provide a comprehensive presentation of the global market for Pharmacogene Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmacogene Testing.

The Pharmacogene Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharmacogene Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, by Technology and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Pharmacogene Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Pharmacogene Testing Market Report

Report Metric	Details
Report Name	Pharmacogene Testing Market
Accounted market size in year	US$ 610 million
Forecasted market size in 2031	US$ 1280 million
CAGR	10.5%
Base Year	year
Forecasted years	2026 - 2031
Segment by Type	Heart Disease Testing Gastrointestinal Disease Testing Infectious Disease Testing Others
Segment by Technology	PCR Technology NGS Technology Gene Chip Technology Others
Segment by Sample	Blood Sample Tissue Sample Saliva Sample Others
Segment by Application	Clinical Treatment Drug Development Health Management Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Australian Clinical Labs, MyHeritage, LabCorp, Myriad Genetics, Gravity Diagnostics, Quest Diagnostics, Gene By Gene（myDNA Inc.）, DNA Diagnostics Center, Sanford Imagenetics, Ambry Genetics, Living DNA, EasyDNA, Pathway Genomics, Centrillion Technology, Color Genomics, Anglia DNA Services, African Ancestry, Canadian DNA Services, DNA Family Check, Alpha Biolaboratories, Test Me DNA, 23 Mofang, Genetic Health, DNA Services of America, Shuwen Biotech, Mapmygenome, Full Genomes
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, by Technology etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmacogene Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Pharmacogene Testing Market growing?

Ans: The Pharmacogene Testing Market witnessing a CAGR of 10.5% during the forecast period 2026-2031.

What is the Pharmacogene Testing Market size in 2031?

Ans: The Pharmacogene Testing Market size in 2031 will be US$ 1280 million.

Who are the main players in the Pharmacogene Testing Market report?

Ans: The main players in the Pharmacogene Testing Market are Australian Clinical Labs, MyHeritage, LabCorp, Myriad Genetics, Gravity Diagnostics, Quest Diagnostics, Gene By Gene（myDNA Inc.）, DNA Diagnostics Center, Sanford Imagenetics, Ambry Genetics, Living DNA, EasyDNA, Pathway Genomics, Centrillion Technology, Color Genomics, Anglia DNA Services, African Ancestry, Canadian DNA Services, DNA Family Check, Alpha Biolaboratories, Test Me DNA, 23 Mofang, Genetic Health, DNA Services of America, Shuwen Biotech, Mapmygenome, Full Genomes

What are the Application segmentation covered in the Pharmacogene Testing Market report?

Ans: The Applications covered in the Pharmacogene Testing Market report are Clinical Treatment, Drug Development, Health Management, Others

What are the Type segmentation covered in the Pharmacogene Testing Market report?

Ans: The Types covered in the Pharmacogene Testing Market report are Heart Disease Testing, Gastrointestinal Disease Testing, Infectious Disease Testing, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Pharmacogene Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Heart Disease Testing

1.2.3 Gastrointestinal Disease Testing

1.2.4 Infectious Disease Testing

1.2.5 Others

1.3 Market by Technology

1.3.1 Global Pharmacogene Testing Market Size Growth Rate by Technology: 2020 VS 2024 VS 2031

1.3.2 PCR Technology

1.3.3 NGS Technology

1.3.4 Gene Chip Technology

1.3.5 Others

1.4 Market by Sample

1.4.1 Global Pharmacogene Testing Market Size Growth Rate by Sample: 2020 VS 2024 VS 2031

1.4.2 Blood Sample

1.4.3 Tissue Sample

1.4.4 Saliva Sample

1.4.5 Others

1.5 Market by Application

1.5.1 Global Pharmacogene Testing Market Growth by Application: 2020 VS 2024 VS 2031

1.5.2 Clinical Treatment

1.5.3 Drug Development

1.5.4 Health Management

1.5.5 Others

1.6 Assumptions and Limitations

1.7 Study Objectives

1.8 Years Considered

2 Global Growth Trends

2.1 Global Pharmacogene Testing Market Perspective (2020-2031)

2.2 Global Pharmacogene Testing Growth Trends by Region

2.2.1 Global Pharmacogene Testing Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Pharmacogene Testing Historic Market Size by Region (2020-2025)

2.2.3 Pharmacogene Testing Forecasted Market Size by Region (2026-2031)

2.3 Pharmacogene Testing Market Dynamics

2.3.1 Pharmacogene Testing Industry Trends

2.3.2 Pharmacogene Testing Market Drivers

2.3.3 Pharmacogene Testing Market Challenges

2.3.4 Pharmacogene Testing Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Pharmacogene Testing Players by Revenue

3.1.1 Global Top Pharmacogene Testing Players by Revenue (2020-2025)

3.1.2 Global Pharmacogene Testing Revenue Market Share by Players (2020-2025)

3.2 Global Top Pharmacogene Testing Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Pharmacogene Testing Revenue

3.4 Global Pharmacogene Testing Market Concentration Ratio

3.4.1 Global Pharmacogene Testing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Pharmacogene Testing Revenue in 2024

3.5 Global Key Players of Pharmacogene Testing Head office and Area Served

3.6 Global Key Players of Pharmacogene Testing, Product and Application

3.7 Global Key Players of Pharmacogene Testing, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Pharmacogene Testing Breakdown Data by Type

4.1 Global Pharmacogene Testing Historic Market Size by Type (2020-2025)

4.2 Global Pharmacogene Testing Forecasted Market Size by Type (2026-2031)

5 Pharmacogene Testing Breakdown Data by Application

5.1 Global Pharmacogene Testing Historic Market Size by Application (2020-2025)

5.2 Global Pharmacogene Testing Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Pharmacogene Testing Market Size (2020-2031)

6.2 North America Pharmacogene Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Pharmacogene Testing Market Size by Country (2020-2025)

6.4 North America Pharmacogene Testing Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Pharmacogene Testing Market Size (2020-2031)

7.2 Europe Pharmacogene Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Pharmacogene Testing Market Size by Country (2020-2025)

7.4 Europe Pharmacogene Testing Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Pharmacogene Testing Market Size (2020-2031)

8.2 Asia-Pacific Pharmacogene Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Pharmacogene Testing Market Size by Region (2020-2025)

8.4 Asia-Pacific Pharmacogene Testing Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Pharmacogene Testing Market Size (2020-2031)

9.2 Latin America Pharmacogene Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Pharmacogene Testing Market Size by Country (2020-2025)

9.4 Latin America Pharmacogene Testing Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Pharmacogene Testing Market Size (2020-2031)

10.2 Middle East & Africa Pharmacogene Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Pharmacogene Testing Market Size by Country (2020-2025)

10.4 Middle East & Africa Pharmacogene Testing Market Size by Country (2026-2031)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Australian Clinical Labs

11.1.1 Australian Clinical Labs Company Details

11.1.2 Australian Clinical Labs Business Overview

11.1.3 Australian Clinical Labs Pharmacogene Testing Introduction

11.1.4 Australian Clinical Labs Revenue in Pharmacogene Testing Business (2020-2025)

11.1.5 Australian Clinical Labs Recent Development

11.2 MyHeritage

11.2.1 MyHeritage Company Details

11.2.2 MyHeritage Business Overview

11.2.3 MyHeritage Pharmacogene Testing Introduction

11.2.4 MyHeritage Revenue in Pharmacogene Testing Business (2020-2025)

11.2.5 MyHeritage Recent Development

11.3 LabCorp

11.3.1 LabCorp Company Details

11.3.2 LabCorp Business Overview

11.3.3 LabCorp Pharmacogene Testing Introduction

11.3.4 LabCorp Revenue in Pharmacogene Testing Business (2020-2025)

11.3.5 LabCorp Recent Development

11.4 Myriad Genetics

11.4.1 Myriad Genetics Company Details

11.4.2 Myriad Genetics Business Overview

11.4.3 Myriad Genetics Pharmacogene Testing Introduction

11.4.4 Myriad Genetics Revenue in Pharmacogene Testing Business (2020-2025)

11.4.5 Myriad Genetics Recent Development

11.5 Gravity Diagnostics

11.5.1 Gravity Diagnostics Company Details

11.5.2 Gravity Diagnostics Business Overview

11.5.3 Gravity Diagnostics Pharmacogene Testing Introduction

11.5.4 Gravity Diagnostics Revenue in Pharmacogene Testing Business (2020-2025)

11.5.5 Gravity Diagnostics Recent Development

11.6 Quest Diagnostics

11.6.1 Quest Diagnostics Company Details

11.6.2 Quest Diagnostics Business Overview

11.6.3 Quest Diagnostics Pharmacogene Testing Introduction

11.6.4 Quest Diagnostics Revenue in Pharmacogene Testing Business (2020-2025)

11.6.5 Quest Diagnostics Recent Development

11.7 Gene By Gene（myDNA Inc.）

11.7.1 Gene By Gene（myDNA Inc.） Company Details

11.7.2 Gene By Gene（myDNA Inc.） Business Overview

11.7.3 Gene By Gene（myDNA Inc.） Pharmacogene Testing Introduction

11.7.4 Gene By Gene（myDNA Inc.） Revenue in Pharmacogene Testing Business (2020-2025)

11.7.5 Gene By Gene（myDNA Inc.） Recent Development

11.8 DNA Diagnostics Center

11.8.1 DNA Diagnostics Center Company Details

11.8.2 DNA Diagnostics Center Business Overview

11.8.3 DNA Diagnostics Center Pharmacogene Testing Introduction

11.8.4 DNA Diagnostics Center Revenue in Pharmacogene Testing Business (2020-2025)

11.8.5 DNA Diagnostics Center Recent Development

11.9 Sanford Imagenetics

11.9.1 Sanford Imagenetics Company Details

11.9.2 Sanford Imagenetics Business Overview

11.9.3 Sanford Imagenetics Pharmacogene Testing Introduction

11.9.4 Sanford Imagenetics Revenue in Pharmacogene Testing Business (2020-2025)

11.9.5 Sanford Imagenetics Recent Development

11.10 Ambry Genetics

11.10.1 Ambry Genetics Company Details

11.10.2 Ambry Genetics Business Overview

11.10.3 Ambry Genetics Pharmacogene Testing Introduction

11.10.4 Ambry Genetics Revenue in Pharmacogene Testing Business (2020-2025)

11.10.5 Ambry Genetics Recent Development

11.11 Living DNA

11.11.1 Living DNA Company Details

11.11.2 Living DNA Business Overview

11.11.3 Living DNA Pharmacogene Testing Introduction

11.11.4 Living DNA Revenue in Pharmacogene Testing Business (2020-2025)

11.11.5 Living DNA Recent Development

11.12 EasyDNA

11.12.1 EasyDNA Company Details

11.12.2 EasyDNA Business Overview

11.12.3 EasyDNA Pharmacogene Testing Introduction

11.12.4 EasyDNA Revenue in Pharmacogene Testing Business (2020-2025)

11.12.5 EasyDNA Recent Development

11.13 Pathway Genomics

11.13.1 Pathway Genomics Company Details

11.13.2 Pathway Genomics Business Overview

11.13.3 Pathway Genomics Pharmacogene Testing Introduction

11.13.4 Pathway Genomics Revenue in Pharmacogene Testing Business (2020-2025)

11.13.5 Pathway Genomics Recent Development

11.14 Centrillion Technology

11.14.1 Centrillion Technology Company Details

11.14.2 Centrillion Technology Business Overview

11.14.3 Centrillion Technology Pharmacogene Testing Introduction

11.14.4 Centrillion Technology Revenue in Pharmacogene Testing Business (2020-2025)

11.14.5 Centrillion Technology Recent Development

11.15 Color Genomics

11.15.1 Color Genomics Company Details

11.15.2 Color Genomics Business Overview

11.15.3 Color Genomics Pharmacogene Testing Introduction

11.15.4 Color Genomics Revenue in Pharmacogene Testing Business (2020-2025)

11.15.5 Color Genomics Recent Development

11.16 Anglia DNA Services

11.16.1 Anglia DNA Services Company Details

11.16.2 Anglia DNA Services Business Overview

11.16.3 Anglia DNA Services Pharmacogene Testing Introduction

11.16.4 Anglia DNA Services Revenue in Pharmacogene Testing Business (2020-2025)

11.16.5 Anglia DNA Services Recent Development

11.17 African Ancestry

11.17.1 African Ancestry Company Details

11.17.2 African Ancestry Business Overview

11.17.3 African Ancestry Pharmacogene Testing Introduction

11.17.4 African Ancestry Revenue in Pharmacogene Testing Business (2020-2025)

11.17.5 African Ancestry Recent Development

11.18 Canadian DNA Services

11.18.1 Canadian DNA Services Company Details

11.18.2 Canadian DNA Services Business Overview

11.18.3 Canadian DNA Services Pharmacogene Testing Introduction

11.18.4 Canadian DNA Services Revenue in Pharmacogene Testing Business (2020-2025)

11.18.5 Canadian DNA Services Recent Development

11.19 DNA Family Check

11.19.1 DNA Family Check Company Details

11.19.2 DNA Family Check Business Overview

11.19.3 DNA Family Check Pharmacogene Testing Introduction

11.19.4 DNA Family Check Revenue in Pharmacogene Testing Business (2020-2025)

11.19.5 DNA Family Check Recent Development

11.20 Alpha Biolaboratories

11.20.1 Alpha Biolaboratories Company Details

11.20.2 Alpha Biolaboratories Business Overview

11.20.3 Alpha Biolaboratories Pharmacogene Testing Introduction

11.20.4 Alpha Biolaboratories Revenue in Pharmacogene Testing Business (2020-2025)

11.20.5 Alpha Biolaboratories Recent Development

11.21 Test Me DNA

11.21.1 Test Me DNA Company Details

11.21.2 Test Me DNA Business Overview

11.21.3 Test Me DNA Pharmacogene Testing Introduction

11.21.4 Test Me DNA Revenue in Pharmacogene Testing Business (2020-2025)

11.21.5 Test Me DNA Recent Development

11.22 23 Mofang

11.22.1 23 Mofang Company Details

11.22.2 23 Mofang Business Overview

11.22.3 23 Mofang Pharmacogene Testing Introduction

11.22.4 23 Mofang Revenue in Pharmacogene Testing Business (2020-2025)

11.22.5 23 Mofang Recent Development

11.23 Genetic Health

11.23.1 Genetic Health Company Details

11.23.2 Genetic Health Business Overview

11.23.3 Genetic Health Pharmacogene Testing Introduction

11.23.4 Genetic Health Revenue in Pharmacogene Testing Business (2020-2025)

11.23.5 Genetic Health Recent Development

11.24 DNA Services of America

11.24.1 DNA Services of America Company Details

11.24.2 DNA Services of America Business Overview

11.24.3 DNA Services of America Pharmacogene Testing Introduction

11.24.4 DNA Services of America Revenue in Pharmacogene Testing Business (2020-2025)

11.24.5 DNA Services of America Recent Development

11.25 Shuwen Biotech

11.25.1 Shuwen Biotech Company Details

11.25.2 Shuwen Biotech Business Overview

11.25.3 Shuwen Biotech Pharmacogene Testing Introduction

11.25.4 Shuwen Biotech Revenue in Pharmacogene Testing Business (2020-2025)

11.25.5 Shuwen Biotech Recent Development

11.26 Mapmygenome

11.26.1 Mapmygenome Company Details

11.26.2 Mapmygenome Business Overview

11.26.3 Mapmygenome Pharmacogene Testing Introduction

11.26.4 Mapmygenome Revenue in Pharmacogene Testing Business (2020-2025)

11.26.5 Mapmygenome Recent Development

11.27 Full Genomes

11.27.1 Full Genomes Company Details

11.27.2 Full Genomes Business Overview

11.27.3 Full Genomes Pharmacogene Testing Introduction

11.27.4 Full Genomes Revenue in Pharmacogene Testing Business (2020-2025)

11.27.5 Full Genomes Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

List of Tables

Table 1. Global Pharmacogene Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Heart Disease Testing

Table 3. Key Players of Gastrointestinal Disease Testing

Table 4. Key Players of Infectious Disease Testing

Table 5. Key Players of Others

Table 6. Global Pharmacogene Testing Market Size Growth Rate by Technology (US$ Million): 2020 VS 2024 VS 2031

Table 7. Key Players of PCR Technology

Table 8. Key Players of NGS Technology

Table 9. Key Players of Gene Chip Technology

Table 10. Key Players of Others

Table 11. Global Pharmacogene Testing Market Size Growth Rate by Sample (US$ Million): 2020 VS 2024 VS 2031

Table 12. Key Players of Blood Sample

Table 13. Key Players of Tissue Sample

Table 14. Key Players of Saliva Sample

Table 15. Key Players of Others

Table 16. Global Pharmacogene Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Pharmacogene Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 18. Global Pharmacogene Testing Market Size by Region (2020-2025) & (US$ Million)

Table 19. Global Pharmacogene Testing Market Share by Region (2020-2025)

Table 20. Global Pharmacogene Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 21. Global Pharmacogene Testing Market Share by Region (2026-2031)

Table 22. Pharmacogene Testing Market Trends

Table 23. Pharmacogene Testing Market Drivers

Table 24. Pharmacogene Testing Market Challenges

Table 25. Pharmacogene Testing Market Restraints

Table 26. Global Pharmacogene Testing Revenue by Players (2020-2025) & (US$ Million)

Table 27. Global Pharmacogene Testing Market Share by Players (2020-2025)

Table 28. Global Top Pharmacogene Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacogene Testing as of 2024)

Table 29. Ranking of Global Top Pharmacogene Testing Companies by Revenue (US$ Million) in 2024

Table 30. Global 5 Largest Players Market Share by Pharmacogene Testing Revenue (CR5 and HHI) & (2020-2025)

Table 31. Global Key Players of Pharmacogene Testing, Headquarters and Area Served

Table 32. Global Key Players of Pharmacogene Testing, Product and Application

Table 33. Global Key Players of Pharmacogene Testing, Date of Enter into This Industry

Table 34. Mergers & Acquisitions, Expansion Plans

Table 35. Global Pharmacogene Testing Market Size by Type (2020-2025) & (US$ Million)

Table 36. Global Pharmacogene Testing Revenue Market Share by Type (2020-2025)

Table 37. Global Pharmacogene Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 38. Global Pharmacogene Testing Revenue Market Share by Type (2026-2031)

Table 39. Global Pharmacogene Testing Market Size by Application (2020-2025) & (US$ Million)

Table 40. Global Pharmacogene Testing Revenue Market Share by Application (2020-2025)

Table 41. Global Pharmacogene Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 42. Global Pharmacogene Testing Revenue Market Share by Application (2026-2031)

Table 43. North America Pharmacogene Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. North America Pharmacogene Testing Market Size by Country (2020-2025) & (US$ Million)

Table 45. North America Pharmacogene Testing Market Size by Country (2026-2031) & (US$ Million)

Table 46. Europe Pharmacogene Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Europe Pharmacogene Testing Market Size by Country (2020-2025) & (US$ Million)

Table 48. Europe Pharmacogene Testing Market Size by Country (2026-2031) & (US$ Million)

Table 49. Asia-Pacific Pharmacogene Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 50. Asia-Pacific Pharmacogene Testing Market Size by Region (2020-2025) & (US$ Million)

Table 51. Asia-Pacific Pharmacogene Testing Market Size by Region (2026-2031) & (US$ Million)

Table 52. Latin America Pharmacogene Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 53. Latin America Pharmacogene Testing Market Size by Country (2020-2025) & (US$ Million)

Table 54. Latin America Pharmacogene Testing Market Size by Country (2026-2031) & (US$ Million)

Table 55. Middle East & Africa Pharmacogene Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 56. Middle East & Africa Pharmacogene Testing Market Size by Country (2020-2025) & (US$ Million)

Table 57. Middle East & Africa Pharmacogene Testing Market Size by Country (2026-2031) & (US$ Million)

Table 58. Australian Clinical Labs Company Details

Table 59. Australian Clinical Labs Business Overview

Table 60. Australian Clinical Labs Pharmacogene Testing Product

Table 61. Australian Clinical Labs Revenue in Pharmacogene Testing Business (2020-2025) & (US$ Million)

Table 62. Australian Clinical Labs Recent Development

Table 63. MyHeritage Company Details

Table 64. MyHeritage Business Overview

Table 65. MyHeritage Pharmacogene Testing Product

Table 66. MyHeritage Revenue in Pharmacogene Testing Business (2020-2025) & (US$ Million)

Table 67. MyHeritage Recent Development

Table 68. LabCorp Company Details

Table 69. LabCorp Business Overview

Table 70. LabCorp Pharmacogene Testing Product

Table 71. LabCorp Revenue in Pharmacogene Testing Business (2020-2025) & (US$ Million)

Table 72. LabCorp Recent Development

Table 73. Myriad Genetics Company Details

Table 74. Myriad Genetics Business Overview

Table 75. Myriad Genetics Pharmacogene Testing Product

Table 76. Myriad Genetics Revenue in Pharmacogene Testing Business (2020-2025) & (US$ Million)

Table 77. Myriad Genetics Recent Development

Table 78. Gravity Diagnostics Company Details

Table 79. Gravity Diagnostics Business Overview

Table 80. Gravity Diagnostics Pharmacogene Testing Product

Table 81. Gravity Diagnostics Revenue in Pharmacogene Testing Business (2020-2025) & (US$ Million)

Table 82. Gravity Diagnostics Recent Development

Table 83. Quest Diagnostics Company Details

Table 84. Quest Diagnostics Business Overview

Table 85. Quest Diagnostics Pharmacogene Testing Product

Table 86. Quest Diagnostics Revenue in Pharmacogene Testing Business (2020-2025) & (US$ Million)

Table 87. Quest Diagnostics Recent Development

Table 88. Gene By Gene（myDNA Inc.） Company Details

Table 89. Gene By Gene（myDNA Inc.） Business Overview

Table 90. Gene By Gene（myDNA Inc.） Pharmacogene Testing Product

Table 91. Gene By Gene（myDNA Inc.） Revenue in Pharmacogene Testing Business (2020-2025) & (US$ Million)

Table 92. Gene By Gene（myDNA Inc.） Recent Development

Table 93. DNA Diagnostics Center Company Details

Table 94. DNA Diagnostics Center Business Overview

Table 95. DNA Diagnostics Center Pharmacogene Testing Product

Table 96. DNA Diagnostics Center Revenue in Pharmacogene Testing Business (2020-2025) & (US$ Million)

Table 97. DNA Diagnostics Center Recent Development

Table 98. Sanford Imagenetics Company Details

Table 99. Sanford Imagenetics Business Overview

Table 100. Sanford Imagenetics Pharmacogene Testing Product

Table 101. Sanford Imagenetics Revenue in Pharmacogene Testing Business (2020-2025) & (US$ Million)

Table 102. Sanford Imagenetics Recent Development

Table 103. Ambry Genetics Company Details

Table 104. Ambry Genetics Business Overview

Table 105. Ambry Genetics Pharmacogene Testing Product

Table 106. Ambry Genetics Revenue in Pharmacogene Testing Business (2020-2025) & (US$ Million)

Table 107. Ambry Genetics Recent Development

Table 108. Living DNA Company Details

Table 109. Living DNA Business Overview

Table 110. Living DNA Pharmacogene Testing Product

Table 111. Living DNA Revenue in Pharmacogene Testing Business (2020-2025) & (US$ Million)

Table 112. Living DNA Recent Development

Table 113. EasyDNA Company Details

Table 114. EasyDNA Business Overview

Table 115. EasyDNA Pharmacogene Testing Product

Table 116. EasyDNA Revenue in Pharmacogene Testing Business (2020-2025) & (US$ Million)

Table 117. EasyDNA Recent Development

Table 118. Pathway Genomics Company Details

Table 119. Pathway Genomics Business Overview

Table 120. Pathway Genomics Pharmacogene Testing Product

Table 121. Pathway Genomics Revenue in Pharmacogene Testing Business (2020-2025) & (US$ Million)

Table 122. Pathway Genomics Recent Development

Table 123. Centrillion Technology Company Details

Table 124. Centrillion Technology Business Overview

Table 125. Centrillion Technology Pharmacogene Testing Product

Table 126. Centrillion Technology Revenue in Pharmacogene Testing Business (2020-2025) & (US$ Million)

Table 127. Centrillion Technology Recent Development

Table 128. Color Genomics Company Details

Table 129. Color Genomics Business Overview

Table 130. Color Genomics Pharmacogene Testing Product

Table 131. Color Genomics Revenue in Pharmacogene Testing Business (2020-2025) & (US$ Million)

Table 132. Color Genomics Recent Development

Table 133. Anglia DNA Services Company Details

Table 134. Anglia DNA Services Business Overview

Table 135. Anglia DNA Services Pharmacogene Testing Product

Table 136. Anglia DNA Services Revenue in Pharmacogene Testing Business (2020-2025) & (US$ Million)

Table 137. Anglia DNA Services Recent Development

Table 138. African Ancestry Company Details

Table 139. African Ancestry Business Overview

Table 140. African Ancestry Pharmacogene Testing Product

Table 141. African Ancestry Revenue in Pharmacogene Testing Business (2020-2025) & (US$ Million)

Table 142. African Ancestry Recent Development

Table 143. Canadian DNA Services Company Details

Table 144. Canadian DNA Services Business Overview

Table 145. Canadian DNA Services Pharmacogene Testing Product

Table 146. Canadian DNA Services Revenue in Pharmacogene Testing Business (2020-2025) & (US$ Million)

Table 147. Canadian DNA Services Recent Development

Table 148. DNA Family Check Company Details

Table 149. DNA Family Check Business Overview

Table 150. DNA Family Check Pharmacogene Testing Product

Table 151. DNA Family Check Revenue in Pharmacogene Testing Business (2020-2025) & (US$ Million)

Table 152. DNA Family Check Recent Development

Table 153. Alpha Biolaboratories Company Details

Table 154. Alpha Biolaboratories Business Overview

Table 155. Alpha Biolaboratories Pharmacogene Testing Product

Table 156. Alpha Biolaboratories Revenue in Pharmacogene Testing Business (2020-2025) & (US$ Million)

Table 157. Alpha Biolaboratories Recent Development

Table 158. Test Me DNA Company Details

Table 159. Test Me DNA Business Overview

Table 160. Test Me DNA Pharmacogene Testing Product

Table 161. Test Me DNA Revenue in Pharmacogene Testing Business (2020-2025) & (US$ Million)

Table 162. Test Me DNA Recent Development

Table 163. 23 Mofang Company Details

Table 164. 23 Mofang Business Overview

Table 165. 23 Mofang Pharmacogene Testing Product

Table 166. 23 Mofang Revenue in Pharmacogene Testing Business (2020-2025) & (US$ Million)

Table 167. 23 Mofang Recent Development

Table 168. Genetic Health Company Details

Table 169. Genetic Health Business Overview

Table 170. Genetic Health Pharmacogene Testing Product

Table 171. Genetic Health Revenue in Pharmacogene Testing Business (2020-2025) & (US$ Million)

Table 172. Genetic Health Recent Development

Table 173. DNA Services of America Company Details

Table 174. DNA Services of America Business Overview

Table 175. DNA Services of America Pharmacogene Testing Product

Table 176. DNA Services of America Revenue in Pharmacogene Testing Business (2020-2025) & (US$ Million)

Table 177. DNA Services of America Recent Development

Table 178. Shuwen Biotech Company Details

Table 179. Shuwen Biotech Business Overview

Table 180. Shuwen Biotech Pharmacogene Testing Product

Table 181. Shuwen Biotech Revenue in Pharmacogene Testing Business (2020-2025) & (US$ Million)

Table 182. Shuwen Biotech Recent Development

Table 183. Mapmygenome Company Details

Table 184. Mapmygenome Business Overview

Table 185. Mapmygenome Pharmacogene Testing Product

Table 186. Mapmygenome Revenue in Pharmacogene Testing Business (2020-2025) & (US$ Million)

Table 187. Mapmygenome Recent Development

Table 188. Full Genomes Company Details

Table 189. Full Genomes Business Overview

Table 190. Full Genomes Pharmacogene Testing Product

Table 191. Full Genomes Revenue in Pharmacogene Testing Business (2020-2025) & (US$ Million)

Table 192. Full Genomes Recent Development

Table 193. Research Programs/Design for This Report

Table 194. Key Data Information from Secondary Sources

Table 195. Key Data Information from Primary Sources

Table 196. Authors List of This Report

List of Figures

Figure 1. Pharmacogene Testing Picture

Figure 2. Global Pharmacogene Testing Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Pharmacogene Testing Market Share by Type: 2024 VS 2031

Figure 4. Heart Disease Testing Features

Figure 5. Gastrointestinal Disease Testing Features

Figure 6. Infectious Disease Testing Features

Figure 7. Others Features

Figure 8. Global Pharmacogene Testing Market Size Comparison by Technology (2020-2031) & (US$ Million)

Figure 9. PCR Technology Features

Figure 10. NGS Technology Features

Figure 11. Gene Chip Technology Features

Figure 12. Others Features

Figure 13. Global Pharmacogene Testing Market Size Comparison by Sample (2020-2031) & (US$ Million)

Figure 14. Blood Sample Features

Figure 15. Tissue Sample Features

Figure 16. Saliva Sample Features

Figure 17. Others Features

Figure 18. Global Pharmacogene Testing Market Size by Application (2020-2031) & (US$ Million)

Figure 19. Global Pharmacogene Testing Market Share by Application: 2024 VS 2031

Figure 20. Clinical Treatment Case Studies

Figure 21. Drug Development Case Studies

Figure 22. Health Management Case Studies

Figure 23. Others Case Studies

Figure 24. Pharmacogene Testing Report Years Considered

Figure 25. Global Pharmacogene Testing Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 26. Global Pharmacogene Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 27. Global Pharmacogene Testing Market Share by Region: 2024 VS 2031

Figure 28. Global Pharmacogene Testing Market Share by Players in 2024

Figure 29. Global Pharmacogene Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 30. The Top 10 and 5 Players Market Share by Pharmacogene Testing Revenue in 2024

Figure 31. North America Pharmacogene Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. North America Pharmacogene Testing Market Share by Country (2020-2031)

Figure 33. United States Pharmacogene Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Canada Pharmacogene Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Europe Pharmacogene Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Europe Pharmacogene Testing Market Share by Country (2020-2031)

Figure 37. Germany Pharmacogene Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. France Pharmacogene Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. U.K. Pharmacogene Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Italy Pharmacogene Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Russia Pharmacogene Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Ireland Pharmacogene Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Asia-Pacific Pharmacogene Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Asia-Pacific Pharmacogene Testing Market Share by Region (2020-2031)

Figure 45. China Pharmacogene Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Japan Pharmacogene Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. South Korea Pharmacogene Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Southeast Asia Pharmacogene Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. India Pharmacogene Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Australia & New Zealand Pharmacogene Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Latin America Pharmacogene Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. Latin America Pharmacogene Testing Market Share by Country (2020-2031)

Figure 53. Mexico Pharmacogene Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 54. Brazil Pharmacogene Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 55. Middle East & Africa Pharmacogene Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 56. Middle East & Africa Pharmacogene Testing Market Share by Country (2020-2031)

Figure 57. Israel Pharmacogene Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 58. Saudi Arabia Pharmacogene Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 59. UAE Pharmacogene Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 60. Australian Clinical Labs Revenue Growth Rate in Pharmacogene Testing Business (2020-2025)

Figure 61. MyHeritage Revenue Growth Rate in Pharmacogene Testing Business (2020-2025)

Figure 62. LabCorp Revenue Growth Rate in Pharmacogene Testing Business (2020-2025)

Figure 63. Myriad Genetics Revenue Growth Rate in Pharmacogene Testing Business (2020-2025)

Figure 64. Gravity Diagnostics Revenue Growth Rate in Pharmacogene Testing Business (2020-2025)

Figure 65. Quest Diagnostics Revenue Growth Rate in Pharmacogene Testing Business (2020-2025)

Figure 66. Gene By Gene（myDNA Inc.） Revenue Growth Rate in Pharmacogene Testing Business (2020-2025)

Figure 67. DNA Diagnostics Center Revenue Growth Rate in Pharmacogene Testing Business (2020-2025)

Figure 68. Sanford Imagenetics Revenue Growth Rate in Pharmacogene Testing Business (2020-2025)

Figure 69. Ambry Genetics Revenue Growth Rate in Pharmacogene Testing Business (2020-2025)

Figure 70. Living DNA Revenue Growth Rate in Pharmacogene Testing Business (2020-2025)

Figure 71. EasyDNA Revenue Growth Rate in Pharmacogene Testing Business (2020-2025)

Figure 72. Pathway Genomics Revenue Growth Rate in Pharmacogene Testing Business (2020-2025)

Figure 73. Centrillion Technology Revenue Growth Rate in Pharmacogene Testing Business (2020-2025)

Figure 74. Color Genomics Revenue Growth Rate in Pharmacogene Testing Business (2020-2025)

Figure 75. Anglia DNA Services Revenue Growth Rate in Pharmacogene Testing Business (2020-2025)

Figure 76. African Ancestry Revenue Growth Rate in Pharmacogene Testing Business (2020-2025)

Figure 77. Canadian DNA Services Revenue Growth Rate in Pharmacogene Testing Business (2020-2025)

Figure 78. DNA Family Check Revenue Growth Rate in Pharmacogene Testing Business (2020-2025)

Figure 79. Alpha Biolaboratories Revenue Growth Rate in Pharmacogene Testing Business (2020-2025)

Figure 80. Test Me DNA Revenue Growth Rate in Pharmacogene Testing Business (2020-2025)

Figure 81. 23 Mofang Revenue Growth Rate in Pharmacogene Testing Business (2020-2025)

Figure 82. Genetic Health Revenue Growth Rate in Pharmacogene Testing Business (2020-2025)

Figure 83. DNA Services of America Revenue Growth Rate in Pharmacogene Testing Business (2020-2025)

Figure 84. Shuwen Biotech Revenue Growth Rate in Pharmacogene Testing Business (2020-2025)

Figure 85. Mapmygenome Revenue Growth Rate in Pharmacogene Testing Business (2020-2025)

Figure 86. Full Genomes Revenue Growth Rate in Pharmacogene Testing Business (2020-2025)

Figure 87. Bottom-up and Top-down Approaches for This Report

Figure 88. Data Triangulation

Figure 89. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Pharmacogene Testing Market Research Report 2025

Published Date: 2025-12-08

Report Code: QYRE-Auto-11C16646

Global Pharmacogene Testing Market Research Report 2025

FEATURED COMPANIES

Pharmacogene Testing Market Size

Pharmacogene Testing Market

Scope of Pharmacogene Testing Market Report

Chapter Outline

FAQ for this report

How fast is Pharmacogene Testing Market growing?

What is the Pharmacogene Testing Market size in 2031?

Who are the main players in the Pharmacogene Testing Market report?

What are the Application segmentation covered in the Pharmacogene Testing Market report?

What are the Type segmentation covered in the Pharmacogene Testing Market report?

FEATURED COMPANIES